Relation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Association of transforming growth factor β1 gene polymorphism with natural clearance of hepatitis C virus

A study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin